Voloridge Investment Management
MRSN

Voloridge Investment Management’s Mersana Therapeutics MRSN Stock Holding History

Voloridge Investment Management’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,009
Closed -$441K – 1523
2022
Q4 		$441K Sell
3,009
-170
-5% -$28.7K ﹤0.01% 1293
2022
Q3 		$537K Buy
+3,179
New +$517K ﹤0.01% 1251
2022
Q1 		– Sell
-3,385
Closed -$526K – 1585
2021
Q4 		$526K Sell
3,385
-473
-12% -$92K ﹤0.01% 1402
2021
Q3 		$910K Buy
+3,858
New +$1.13M 0.01% 1310

Other funds holding MRSN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return